Indian pharmaceutical companies Sun Pharma, Lupin, and Dr Reddy's Laboratories are conducting recalls in the US due to ...

Sun Pharma, Lupin and Dr Reddy's Laboratories are recalling various drugs in the US due to manufacturing issues and product mix-ups, as reported by the US health regulator.

New Delhi, Domestic drug majors Sun Pharma, Lupin and Dr Reddy's Laboratories are recalling drugs in the US market due to manufacturing issues and product mix up, according to the US health regulator.

Three major Indian pharmaceutical companies are recalling drugs in the United States. Sun Pharma is recalling ...

The Carbamazepine extended-release tablets are indicated for use as an anti-convulsant drug and also for the treatment of the ...

Lupin receives USFDA approval for generic Liraglutide Injection and Glucagon, expanding access to diabetes treatments.

Zydus Lifesciences receives tentative USFDA approval for its generic Ibrutinib tablets, used to treat various blood cancers.

Ibrutinib tablets had annual sales of $2,148.9 million in the United States, as per the IQVIA data dated May 2025, Zydus Life ...

A Form 483 is issued at the conclusion of an inspection when USFDA investigators observe conditions that may be in violation ...

Zydus Lifesciences Ltd on Thursday said it has received tentative approval from the US health regulatory agency for its generic version of cancer treatment drug Ibrutinib tablets.

Pharmaceutical company Lupin has received approval from the US Food and Drug Administration (USFDA) to market generic diabetes drugs.

Dr Reddy’s received a Form 483 with seven USFDA observations after inspecting its Srikakulam manufacturing plant in Andhra ...